Oppenheimer Asset Management Inc. Gilead Sciences, Inc. Transaction History

Oppenheimer Asset Management Inc.

  • $8.4 Billion
  • Q2 2025

A detailed history of Oppenheimer Asset Management Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 129,697 shares of GILD stock, worth $15.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
129,697
Previous 125,132 3.65%
Holding current value
$15.6 Million
Previous $14 Million 2.55%
% of portfolio
0.17%
Previous 0.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
BUY
$96.91 - $113.0 $442,394 - $515,845
4,565 Added 3.65%
129,697 $14.4 Million
Q1 2025

Apr 22, 2025
SELL
$89.14 - $117.41 $375,101 - $494,061
-4,208 Reduced 3.25%
125,132 $14 Million
Q4 2024

Feb 04, 2025
SELL
$83.95 - $97.9 $4.6 Million - $5.37 Million
-54,832 Reduced 29.77%
129,340 $11.9 Million
Q3 2024

Nov 05, 2024
BUY
$66.59 - $83.99 $63,127 - $79,622
948 Added 0.52%
184,172 $15.4 Million
Q2 2024

Aug 08, 2024
BUY
$63.15 - $72.88 $1.97 Million - $2.27 Million
31,148 Added 20.48%
183,224 $12.6 Million
Q1 2024

May 06, 2024
SELL
$71.58 - $87.29 $1.81 Million - $2.21 Million
-25,311 Reduced 14.27%
152,076 $11.1 Million
Q4 2023

Feb 13, 2024
BUY
$73.27 - $83.09 $351,842 - $398,998
4,802 Added 2.78%
177,387 $14.4 Million
Q3 2023

Nov 07, 2023
BUY
$73.94 - $80.67 $428,704 - $467,724
5,798 Added 3.48%
172,585 $12.9 Million
Q2 2023

Aug 02, 2023
SELL
$76.01 - $86.7 $1.12 Million - $1.28 Million
-14,764 Reduced 8.13%
166,787 $12.9 Million
Q1 2023

May 10, 2023
BUY
$77.31 - $88.08 $52,184 - $59,454
675 Added 0.37%
181,551 $15.1 Million
Q4 2022

Feb 06, 2023
BUY
$62.32 - $89.47 $156,485 - $224,659
2,511 Added 1.41%
180,876 $15.5 Million
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $2.09 Million - $2.38 Million
35,046 Added 24.45%
178,365 $11 Million
Q2 2022

Aug 08, 2022
BUY
$57.72 - $65.01 $36,248 - $40,826
628 Added 0.44%
143,319 $8.86 Million
Q1 2022

May 12, 2022
BUY
$57.92 - $72.58 $325,104 - $407,391
5,613 Added 4.09%
142,691 $8.48 Million
Q4 2021

Feb 02, 2022
BUY
$64.88 - $73.64 $2.1 Million - $2.38 Million
32,381 Added 30.93%
137,078 $9.95 Million
Q3 2021

Nov 12, 2021
BUY
$67.69 - $73.03 $45,149 - $48,711
667 Added 0.64%
104,697 $7.31 Million
Q2 2021

Aug 03, 2021
BUY
$63.47 - $69.35 $2.38 Million - $2.6 Million
37,488 Added 56.34%
104,030 $7.16 Million
Q1 2021

May 17, 2021
BUY
$60.0 - $68.46 $203,520 - $232,216
3,392 Added 5.37%
66,542 $4.3 Million
Q4 2020

Feb 11, 2021
SELL
$56.65 - $64.55 $57,103 - $65,066
-1,008 Reduced 1.57%
63,150 $3.68 Million
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $702,413 - $883,162
-11,311 Reduced 14.99%
64,158 $4.06 Million
Q2 2020

Aug 11, 2020
BUY
$72.34 - $84.0 $35,012 - $40,656
484 Added 0.65%
75,469 $5.81 Million
Q1 2020

May 08, 2020
BUY
$62.63 - $80.22 $2.95 Million - $3.78 Million
47,164 Added 169.53%
74,985 $5.61 Million
Q4 2019

Feb 07, 2020
SELL
$61.62 - $67.78 $91,505 - $100,653
-1,485 Reduced 5.07%
27,821 $1.81 Million
Q3 2019

Oct 31, 2019
BUY
$62.51 - $69.0 $1.28 Million - $1.41 Million
20,425 Added 229.99%
29,306 $1.86 Million
Q2 2019

Aug 09, 2019
BUY
$61.87 - $69.38 $17,880 - $20,050
289 Added 3.36%
8,881 $599,000
Q1 2019

Apr 24, 2019
SELL
$62.53 - $70.05 $613,419 - $687,190
-9,810 Reduced 53.31%
8,592 $559,000
Q4 2018

Jan 30, 2019
SELL
$60.54 - $79.0 $100,012 - $130,508
-1,652 Reduced 8.24%
18,402 $1.15 Million
Q3 2018

Oct 26, 2018
BUY
$71.28 - $78.92 $791,208 - $876,012
11,100 Added 123.97%
20,054 $1.55 Million
Q2 2018

Aug 10, 2018
BUY
$64.88 - $75.68 $28,806 - $33,601
444 Added 5.22%
8,954 $634,000
Q1 2018

May 09, 2018
BUY
$72.84 - $88.8 $144,296 - $175,912
1,981 Added 30.34%
8,510 $642,000
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $470,806 - $558,033
6,529
6,529 $530,000

Others Institutions Holding GILD

# of Institutions
2,342
Shares Held
1.03B
Call Options Held
12.1M
Put Options Held
9.13M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $151B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email